Премини към основното съдържание
Home
language-selector-globe Bulgaria | bg
Choose Location
  • Americas
  • Asia Pacific
  • Europe
  • International
  • Middle East & Africa
Argentina | Español
Brazil | Português
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Mexico | Español
United States | English
Australia | English
Bangladesh | English
Hong Kong S.A.R. | 繁體中文
India | English
Indonesia | English
Japan | 日本語
Korea | 한국어
Mainland China | 中文
Malaysia | English
Pakistan | English
Philippines | English
Singapore | English
Taiwan | 繁體中文
Thailand | ภาษาไทย
Austria | Deutsch
Belgium | Français
Belgium | Nederlands
Bulgaria | Български
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hungary | Magyar
Ireland | English
Italy | Italiano
Latvia | Latvian
Lithuania | Lithuanian
Netherlands | Nederlands
Norway | Norsk
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Serbia | Srpski
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Türkiye | Türkçe
United Kingdom | English
Global | English
Novartis Foundation | English
Egypt | English
Israel | עברית
Saudi Arabia | العربية
South Africa | English
language-selector-globe Bulgaria
Choose Location
Americas Asia Pacific Europe International Middle East & Africa
Argentina | Español
Australia | English
Austria | Deutsch
Bangladesh | English
Belgium | Français
Belgium | Nederlands
Brazil | Português
Bulgaria | Български
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Egypt | English
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hong Kong S.A.R. | 繁體中文
Hungary | Magyar
India | English
Indonesia | English
Ireland | English
Israel | עברית
Italy | Italiano
Japan | 日本語
Korea | 한국어
Latvia | Latvian
Lithuania | Lithuanian
Mainland China | 中文
Malaysia | English
Mexico | Español
Netherlands | Nederlands
Norway | Norsk
Global | English
Novartis Foundation | English
Pakistan | English
Philippines | English
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Saudi Arabia | العربية
Serbia | Srpski
Singapore | English
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
South Africa | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Taiwan | 繁體中文
Thailand | ภาษาไทย
Türkiye | Türkçe
United Kingdom | English
United States | English
    • За нас 
      • Новартис в България 
      • Нашата стратегия 
        • Иновативни лекарства 
      • Хора и Култура 
      • Контакти 
      За нас За нас
    • Пациенти и болногледачи 
      • Аз само да попитам: твоят здравен консултант 
      • Ангажиментът на Новартис към пациентите и лицата, които се грижат за тях 
      • Съобщаване на нежелани реакции 
      • Аз само да попитам: твоят здравен портал 
      Пациенти и болногледачи Пациенти и болногледачи
    • Здравни специалисти 
      • Материали за здравни специалисти 
      • Новартис проекти 
      • Съобщаване на нежелани реакции 
      • Клинични проучвания на Новартис 
      Здравни специалисти Здравни специалисти
    • ESG 
      • Етика, Риск и Законосъобразност 
      • Разширяване на достъпа до здравеопазване 
      • Опазване на природата 
      • Световно здраве 
      • Етично поведение 
        • Етичен кодекс 
        • SpeakUp 
      Околна среда, социални и правни въпроси ESG
    • Новини 
      • Медийни контакти 
      • Новини 
      Новини Новини
    • Кариера 
      • Търсене на кариера 
      • Награди и признание 
      Кариера Кариера
    • Коронавирус 
      Коронавирус Коронавирус
    Новартис България Начало
  1. Начало
  2. Кариера
  3. Търсене на кариера
  • Sort by Sort ascending
  • Длъжност Sort ascending
  • Място
  • Местоположение
  • дивизия
  • Бизнес
  • Functional Area
  • Дата
Длъжност Sort ascending Място Местоположение дивизия Бизнес Functional Area Дата
Tax Specialist Mumbai (Head Office) India Finance Corporate Audit & Finance Окт. 10, 2024
Senior Manager - Direct tax Mumbai (Head Office) India Finance Corporate Audit & Finance Окт. 10, 2024
Revenue Deduction & Accounting Statutory Lead Warsaw Poland Finance CTS Audit & Finance Окт. 10, 2024
Global R2R PEC Automation Expert Hyderabad (Office) India Finance CTS Audit & Finance Окт. 09, 2024
Data Analyst, Digital Finance Hyderabad (Office) India Operations Innovative Medicines Audit & Finance Окт. 09, 2024
Manager, Digital Finance Hyderabad (Office) India Finance Innovative Medicines Audit & Finance Окт. 09, 2024
LDC Core Enablement Business and IT Controls Hyderabad (Office) India Operations CTS Audit & Finance Окт. 09, 2024
General Accounting Manager INSURGENTES Mexico Finance CTS Audit & Finance Окт. 09, 2024
Finance Control and Compliance US Manager INSURGENTES Mexico Finance CTS Audit & Finance Окт. 08, 2024
Senior Financial Analyst - Digital Finance Hyderabad (Office) India Finance Corporate Audit & Finance Окт. 08, 2024
R2R Senior Specialist - GL & Reporting Selangor Malaysia Finance CTS Audit & Finance Окт. 08, 2024
Senior Finance Specialist – Digital Analytics and Operations Barcelona Gran Vía Spain Finance Innovative Medicines Audit & Finance Окт. 08, 2024
Expert Analyst – Management Reporting Prague Czech Republic Finance Corporate Audit & Finance Окт. 08, 2024
FRA Specialist - Asset Management Prague Czech Republic Finance CTS Audit & Finance Окт. 08, 2024
Global Finance Master Data Sr Specialist INSURGENTES Mexico Finance CTS Audit & Finance Окт. 08, 2024
Commercial BPA Manager Montreal Canada International Innovative Medicines Audit & Finance Окт. 08, 2024
Chef commercial BPA Montreal Canada International Innovative Medicines Audit & Finance Окт. 08, 2024
P2P Service Delivery (SD) Lead NGSC INSURGENTES Mexico Finance CTS Audit & Finance Окт. 07, 2024
FC&C Head - HUB/ECI Hyderabad (Office) India Finance CTS Audit & Finance Окт. 07, 2024
Tax Manager (m/w/d) Nuremberg (Non-Sales Force) (Novartis Pharma GmbH) Germany Finance Corporate Audit & Finance Окт. 06, 2024
Manager, Financial Control & Compliance (FC&C) Head Office (Japan) (Pharmaceuticals) Japan Finance CTS Audit & Finance Окт. 06, 2024
Site Finance Head Morris Plains USA Finance Innovative Medicines Audit & Finance Окт. 04, 2024
Global FC&C Process Expert (Senior Manager) PIN-PCA Prague Czech Republic Finance CTS Audit & Finance Окт. 03, 2024
Source to Pay Business Partner Argentina / Chile INSURGENTES Mexico Finance CTS Audit & Finance Окт. 03, 2024
Assistant Manager - FC&C Hyderabad (Office) India Finance CTS Audit & Finance Окт. 03, 2024
P2P Process Excellence INSURGENTES Mexico Operations CTS Audit & Finance Окт. 02, 2024
R2R Senior Specialist - Inventory Selangor Malaysia Finance CTS Audit & Finance Окт. 02, 2024
Senior Product Manager, Digital Finance Barcelona Gran Vía Spain Finance Corporate Audit & Finance Окт. 01, 2024
Business Planning Analysis Manager / Analyst INSURGENTES Mexico Biomedical Research CTS Audit & Finance Септ. 27, 2024
Procure to Pay Business Partner GDD and M&A SPOC INSURGENTES Mexico Operations CTS Audit & Finance Септ. 27, 2024
Comptable Général(e) Expérimenté(e) H/F Paris Headquarter (Novartis Pharma S.A.S.) France Finance CTS Audit & Finance Септ. 27, 2024
Senior FRA Specialist GL Prague Czech Republic Finance CTS Audit & Finance Септ. 26, 2024
Order Management Specialist INSURGENTES Mexico Finance Innovative Medicines Audit & Finance Септ. 25, 2024
Order Management Specialist - Temporary INSURGENTES Mexico Finance CTS Audit & Finance Септ. 25, 2024
Financial IT Compliance Senior Specialist Prague Czech Republic Finance CTS Audit & Finance Септ. 25, 2024
Financial IT Compliance Manager Prague Czech Republic Finance CTS Audit & Finance Септ. 25, 2024
S2P Business Partner (Korean speaker) Selangor Malaysia Finance CTS Audit & Finance Септ. 24, 2024
Revenue Accounting Supervisor Shanghai (Shanghai) China Finance CTS Audit & Finance Септ. 24, 2024
Senior Manager ERP Assurance Hyderabad (Office) India Finance CTS Audit & Finance Септ. 23, 2024
Financial Analyst - SoD Ops Hyderabad (Office) India Finance Corporate Audit & Finance Септ. 17, 2024
RLT Sasayama_Associate_Finance Business Planning and Analysis Sasayama Japan Finance Innovative Medicines Audit & Finance Септ. 17, 2024
R2R Lead Israel Israel Israel Finance CTS Audit & Finance Септ. 16, 2024
FRA Analyst Treasury and Cash Management / Analitik - specialist Ljubljana Slovenia Finance CTS Audit & Finance Септ. 15, 2024
Analitik - specialist / FRA Analyst-specialist Ljubljana Slovenia Finance CTS Audit & Finance Септ. 15, 2024
Financial Accounting Specialist (m/w/d) Schaftenau Austria Finance CTS Audit & Finance Септ. 13, 2024
Finance Project Specialist Moscow (City) Russian Fed. Finance Innovative Medicines Audit & Finance Септ. 11, 2024
Record to Report Sr Specialist INSURGENTES Mexico Operations CTS Audit & Finance Септ. 10, 2024
Record to Report Sr Specialist Intercompany INSURGENTES Mexico Operations CTS Audit & Finance Септ. 10, 2024
Record to Report Sr Specialist US INSURGENTES Mexico Operations CTS Audit & Finance Септ. 10, 2024
Fixed Assets Sr Specialist INSURGENTES Mexico Operations CTS Audit & Finance Септ. 10, 2024

Pagination

  • 1
  • 2
  • › Next page

Новартис България

Навигация
  • Пациенти и болногледачи
  • Здравни специалисти
  • ESG
  • Новини
  • Кариера
Медиен център
  • Архив
  • Новини
Нашето портфолио
  • Клинични проекти на Новартис
Други сайтове на Новартис
  • Глобален сайт
Footer Bottom
© 2024 Новартис АГ
  • Политика за поверителност
  • Условия на ползване
  • Достъп от мрежата
  • Настройки за бисквитки
  • Навигация на сайта
Директория на сайта на Новартис
Тази страница е предназначена за обществеността в България